DaVita Inc. (DVA) stock
DVANYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3044% below fair value
$174.56+0.49 (+0.28%)
Close on Nov 13, 2026Market cap $10.98BP/E 12.9Yield –
DaVita EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
DaVita's EPS for the twelve months ending Sep 30, 2026 was $13.58, up 39.9% year over year. For fiscal 2025 it was $9.84, down 8.3% from the year before. Over ten years it grew 22.9% a year on average. The highest annual figure on record is $10.73 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.84 | -8.3% |
| FY2024 | Dec 31, 2024 | $10.73 | +44.6% |
| FY2023 | Dec 31, 2023 | $7.42 | +26.8% |
| FY2022 | Dec 31, 2022 | $5.85 | -34.3% |
| FY2021 | Dec 31, 2021 | $8.90 | +41.0% |
| FY2020 | Dec 31, 2020 | $6.31 | +19.7% |
| FY2019 | Dec 31, 2019 | $5.27 | +472.8% |
| FY2018 | Dec 31, 2018 | $0.92 | -73.5% |
| FY2017 | Dec 31, 2017 | $3.47 | -19.1% |
| FY2016 | Dec 31, 2016 | $4.29 | +243.2% |
| FY2015 | Dec 31, 2015 | $1.25 | -62.5% |
| FY2014 | Dec 31, 2014 | $3.33 | +12.9% |
| FY2013 | Dec 31, 2013 | $2.95 | +7.7% |
| FY2012 | Dec 31, 2012 | $2.74 | +10.5% |
| FY2011 | Dec 31, 2011 | $2.48 | +25.9% |
| FY2010 | Dec 31, 2010 | $1.97 | -3.0% |
| FY2009 | Dec 31, 2009 | $2.03 | +15.0% |
| FY2008 | Dec 31, 2008 | $1.76 | -0.6% |
| FY2007 | Dec 31, 2007 | $1.77 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.40 | +66.7% |
| Q2 FY2026 | Jun 30, 2026 | $4.02 | +55.8% |
| Q1 FY2026 | Mar 31, 2026 | $2.87 | +43.5% |
| Q4 FY2025 | Dec 31, 2025 | $3.29 | +6.5% |
| Q3 FY2025 | Sep 30, 2025 | $2.04 | -18.4% |
| Q2 FY2025 | Jun 30, 2025 | $2.58 | +3.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.00 | -24.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.09 | +90.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.50 | -4.6% |
| Q2 FY2024 | Jun 30, 2024 | $2.50 | +30.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.65 | +112.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.62 | +118.9% |
| Q3 FY2023 | Sep 30, 2023 | $2.62 | +131.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.91 | -17.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.25 | -22.4% |
| Q4 FY2022 | Dec 31, 2022 | $0.74 | -58.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.13 | -52.1% |
| Q2 FY2022 | Jun 30, 2022 | $2.30 | -12.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.61 | -23.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.79 | +19.3% |
| Q3 FY2021 | Sep 30, 2021 | $2.36 | +84.4% |
| Q2 FY2021 | Jun 30, 2021 | $2.64 | +63.0% |
| Q1 FY2021 | Mar 31, 2021 | $2.09 | +10.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.50 | -20.2% |
| Q3 FY2020 | Sep 30, 2020 | $1.28 | +34.7% |
| Q2 FY2020 | Jun 30, 2020 | $1.62 | -1.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.89 | +110.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.88 | – |
| Q3 FY2019 | Sep 30, 2019 | $0.95 | – |
| Q2 FY2019 | Jun 30, 2019 | $1.64 | +7.2% |
| Q1 FY2019 | Mar 31, 2019 | $0.90 | -8.2% |
| Q4 FY2018 | Dec 31, 2018 | -$0.90 | -154.9% |
| Q3 FY2018 | Sep 30, 2018 | -$0.82 | – |
| Q2 FY2018 | Jun 30, 2018 | $1.53 | +135.4% |
| Q1 FY2018 | Mar 31, 2018 | $0.98 | -57.2% |
| Q4 FY2017 | Dec 31, 2017 | $1.64 | +105.0% |
| Q3 FY2017 | Sep 30, 2017 | -$1.12 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.65 | – |
| Q1 FY2017 | Mar 31, 2017 | $2.29 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.80 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?